HPS Reappoints Tony Wyatt as Chief Executive Officer

It is with great pleasure that the HPS Board announces the reappointment of Tony Wyatt as Chief Executive Offcer for a further two year term.

Dr Andrew Holsman, Chairman of HPS’s Board, shares the Board’s delight at Tony’s reappointment as Chief Executive Offcer, and its confdence in the business’ future sustainability and growth prospects despite the numerous challenges arising from changes in Government health policy.

“In a time of great change, Tony’s experience and leadership is essential to our business aspirations. We congratulate Tony on his successful reappointment and look forward to HPS’s next phase under the assured direction, guidance and experience of a committed and passionate Chief Executive Offcer and his team,” says Dr Holsman.

Throughout his frst term as Chief Executive Offcer, Tony has achieved numerous successes, including but not limited to;

  • Future proofng the business through the successful re-signing of the national Healthscope contract
  • The successful re-signing of the national Little Company of Mary contract
  • The re-signing of the St Andrew’s Hospital contract
  • The repositioning of HPS in the national industry through Tony’s excellent work on chemotherapy drugs
  • The development of a new structure and a clearly defned strategic direction
  • The development of a highly skilled, highly motivated, and high achieving Executive team
  • Negotiation and implementation of HPS’s network of pharmacies Pharmacist Enterprise Agreement

Samantha Greaves, Board Member and Strategic Projects Manager says “over the last two years, Tony has piloted HPS’s Executive team with clear focus and determination. We look forward to continuing to work with Tony to meet the strategic goals of the business.”

Additionally, Janene Garde, Board Member and Clinical Publicist, believes the future will see HPS apply its considerable expertise to further develop innovative solutions for the beneft of clients and their patients.

Tony has an incredible depth of pharmacy experience spanning 34 years in the industry, and has been part of HPS’ management team for more than eight years, appointed to Chief Executive Offcer in July 2011.

Prior to partnering with HPS, Tony owned and operated various hospital pharmacies across Melbourne, and held the position of Managing Partner with a large hospital pharmacy business from 1998 to 2003.

Since 2003, Tony has gathered a wealth of experience within HPS, first as Pharmacist In-Charge at Brunswick, then as State Manager for Victoria and Tasmania. Tony has played an integral role in developing HPS and its network of pharmacies since 2009, acting in the position of Joint Chief Operating Officer, providing focused and competent leadership whilst the business considered its long term CEO requirements.

In addition to these responsibilities, Tony has been a member of HPS’s Board since 2005. Other accolades include a Board Member of St Paul’s Drug Rehabilitation Centre as a Non-Executive Director, guest speaking at the AUSMED/ANF study day, and graduate of AICD in 2007.

HPS’s Board Member and General Manager – Hospitals, Tin Huynh, says “Tony’s reappointment as CEO reaffirms the Board’s confidence in Tony to lead the business and execute the strategic plan in the coming years.

His reappointment ensures HPS retains the valuable skills and experience of Tony to lead us through a challenging, yet exciting, period for HPS and the pharmacy industry in general.”

On behalf of HPS and its network of pharmacies, we congratulate Tony on his reappointment to the position of Chief Executive Officer as we look towards his next term with much excitement and anticipation as he guides the business to future successes.